Journal article
Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes
Abstract
AIMS: Bleeding in patients with coronary artery disease has been linked with adverse outcomes. We examined the incidence and outcomes after bleeding in 20 078 patients with acute coronary syndromes (ACS) enrolled in the OASIS-5 trial who were treated with fondaparinux or the low-molecular weight heparin, enoxaparin.
METHODS AND RESULTS: Nine hundred and ninety (4.9%) patients developed major bleeding and 423 (2.1%) developed minor bleeding. …
Authors
Budaj A; Eikelboom JW; Mehta SR; Afzal R; Chrolavicius S; Bassand J-P; Fox KAA; Wallentin L; Peters RJG; Granger CB
Journal
European Heart Journal, Vol. 30, No. 6, pp. 655–661
Publisher
Oxford University Press (OUP)
Publication Date
March 2009
DOI
10.1093/eurheartj/ehn358
ISSN
0195-668X